Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT02287493
Brief Summary:
In a prospective, non-interventional, monocentric observational study the pharmacokinetic properties of selected antiinfective drugs during sustained low-efficiency dialysis (SLED) will be analyzed.
Detailed Description:
Antibiotic concentrations are measured whilst patients receive SLED for renal replacement therapy. The plasma specimens will be quantified using high Performance liquid chromatography (HPLC).
Primary endpoint:
\- Plasma levels of antiinfectives during SLED
Secondary endpoints:
* mortality
* length of stay at the intensive care unit (ICU) and hospital
* clinical cure of infections
Inclusion criteria:
* age: \> 18 years
* patients under SLED
* antiinfective treatment
exclusion criteria:
\- missing informed consent
Study:
NCT02287493
Study Brief:
Protocol Section:
NCT02287493